GGrantIndex
Sort

50,496 grants matching lung cancer

Succinylation and Malonylation as Novel Protein Modifications in Cancer

$584,331
Hening Lin · Cornell University · R01 · FY2015 · CA

Genetic Epidemiology of Lung Cancer

$584,279
Ann G Schwartz · Wayne State University · R01 · FY2009 · CA

Studies of Non-Ionizing Radiation-Related Cancer

$584,244
Daryl Freedman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

RCT of a Motivational Decision Support System for Smokers with SMI

$584,175
Mary Frances Brunette · Dartmouth College · R01 · FY2014 · CA

Targeting brain and bone metastases in metastatic breast cancer for improved patient survival

$584,152
Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA

Engineering immunotherapeutic probiotics to mitigate irAE

$584,146
Tal Danino · Columbia Univ New York Morningside · U01 · FY2022 · CA

PennPET Explorer Scanner With Scalable Axial Length for Total Body PET Imaging

$584,145
Joel S Karp · University Of Pennsylvania · R01 · FY2022 · CA

Immunotoxicity of Workplace Xenobiotics

$584,098
National Institute Of Environmental Health Sciences · Y01 · FY2010 · ES

Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A

$584,086
Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2020 · CA

Addressing racial disparities in lung cancer screening

$584,078
Melinda Aldrich · Vanderbilt University Medical Center · R01 · FY2025 · CA

Taxi STEP (Social networks, Technology, and Exercise through Pedometers)

$583,980
Francesca M Gany · Sloan-Kettering Inst Can Research · U01 · FY2016 · MD

FRONTIERS: Foreign-Born Latinos Cancer Screening

$583,972
John Heintzman · Oregon Health & Science University · R01 · FY2022 · CA

EARLY DETECTION OF LUNG CANCER THROUGH MOLECULAR ANALYSES OF SINGLE EXTRACELLULAR VESICLES

$583,969
The General Hospital Corporation · · FY2019 · Department of the Army

Targeting plasticity in lung cancer

$583,845
Tuomas Tammela · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport

$583,778
Aleem Gangjee · Duquesne University · R01 · FY2013 · CA

The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis

$583,776
William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA

Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model

$583,741
Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2012 · CA

Assessing the Impact of State Preemption Laws

$583,735
Sunday Azagba · Pennsylvania State University, The · R01 · FY2022 · CA

Therapeutic Targeting Mitochondrial C1 Metabolism

$583,716
Larry H. Matherly · Wayne State University · R01 · FY2024 · CA

Project 2: Identifying Metabolic vulnerabilities and targets in cancers with mutations in hamartoma genes

$583,714
David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2018 · CA

A blood test to identify prostate cancer patients at risk for visceral metastasis

$583,697
Edwin Melencio Posadas · Cedars-Sinai Medical Center · R01 · FY2019 · CA

GD2 CART FOR LUNG CANCER

$583,652
University Of North Carolina At Chapel Hill · · FY2022 · Defense Health Agency

Regulating cell fate and shaping the body plan during morphogenesis and their alteration during oncogenesis

$583,645
Mark Peifer · Univ Of North Carolina Chapel Hill · R35 · FY2019 · GM

Regulating cell fate and shaping the body plan during morphogenesis and their alteration during oncogenesis

$583,645
Mark Peifer · Univ Of North Carolina Chapel Hill · R35 · FY2020 · GM

Regulating cell fate and shaping the body plan during morphogenesis and their alteration during oncogenesis

$583,645
Mark Peifer · Univ Of North Carolina Chapel Hill · R35 · FY2017 · GM